Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Biologic Drugs Market Growth 2022-2028

  • LP 4931560
  • 109 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Biologic Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Biologic Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Biologic Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Biologic Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biologic Drugs market, reaching US$ million by the year 2028. As for the Europe Biologic Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Biologic Drugs players cover Roche, Abbott Laboratories, Johnson & Johnson, and Merck & Co., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Humira

Remicade

Rituxan

Enbrel

Lantus

Avastin

Herceptin

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Diabetes

Inflammation

Auto-Immune Diseases

Blood Diseases

Cardiovascular Diseases

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Roche

Abbott Laboratories

Johnson & Johnson

Merck & Co.

Pfizer

Amgen

Sanofi

Novartis

Eli Lilly

Amgen

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biologic Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Biologic Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Biologic Drugs by Country/Region, 2017, 2022 & 2028

2.2 Biologic Drugs Segment by Type

2.2.1 Humira

2.2.2 Remicade

2.2.3 Rituxan

2.2.4 Enbrel

2.2.5 Lantus

2.2.6 Avastin

2.2.7 Herceptin

2.2.8 Others

2.3 Biologic Drugs Sales by Type

2.3.1 Global Biologic Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Biologic Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Biologic Drugs Sale Price by Type (2017-2022)

2.4 Biologic Drugs Segment by Application

2.4.1 Diabetes

2.4.2 Inflammation

2.4.3 Auto-Immune Diseases

2.4.4 Blood Diseases

2.4.5 Cardiovascular Diseases

2.4.6 Others

2.5 Biologic Drugs Sales by Application

2.5.1 Global Biologic Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Biologic Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Biologic Drugs Sale Price by Application (2017-2022)

3 Global Biologic Drugs by Company

3.1 Global Biologic Drugs Breakdown Data by Company

3.1.1 Global Biologic Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Biologic Drugs Sales Market Share by Company (2020-2022)

3.2 Global Biologic Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Biologic Drugs Revenue by Company (2020-2022)

3.2.2 Global Biologic Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Biologic Drugs Sale Price by Company

3.4 Key Manufacturers Biologic Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biologic Drugs Product Location Distribution

3.4.2 Players Biologic Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Biologic Drugs by Geographic Region

4.1 World Historic Biologic Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Biologic Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Biologic Drugs Annual Revenue by Geographic Region

4.2 World Historic Biologic Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Biologic Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Biologic Drugs Annual Revenue by Country/Region

4.3 Americas Biologic Drugs Sales Growth

4.4 APAC Biologic Drugs Sales Growth

4.5 Europe Biologic Drugs Sales Growth

4.6 Middle East & Africa Biologic Drugs Sales Growth

5 Americas

5.1 Americas Biologic Drugs Sales by Country

5.1.1 Americas Biologic Drugs Sales by Country (2017-2022)

5.1.2 Americas Biologic Drugs Revenue by Country (2017-2022)

5.2 Americas Biologic Drugs Sales by Type

5.3 Americas Biologic Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biologic Drugs Sales by Region

6.1.1 APAC Biologic Drugs Sales by Region (2017-2022)

6.1.2 APAC Biologic Drugs Revenue by Region (2017-2022)

6.2 APAC Biologic Drugs Sales by Type

6.3 APAC Biologic Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Biologic Drugs by Country

7.1.1 Europe Biologic Drugs Sales by Country (2017-2022)

7.1.2 Europe Biologic Drugs Revenue by Country (2017-2022)

7.2 Europe Biologic Drugs Sales by Type

7.3 Europe Biologic Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biologic Drugs by Country

8.1.1 Middle East & Africa Biologic Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Biologic Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Biologic Drugs Sales by Type

8.3 Middle East & Africa Biologic Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Biologic Drugs

10.3 Manufacturing Process Analysis of Biologic Drugs

10.4 Industry Chain Structure of Biologic Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Biologic Drugs Distributors

11.3 Biologic Drugs Customer

12 World Forecast Review for Biologic Drugs by Geographic Region

12.1 Global Biologic Drugs Market Size Forecast by Region

12.1.1 Global Biologic Drugs Forecast by Region (2023-2028)

12.1.2 Global Biologic Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Biologic Drugs Forecast by Type

12.7 Global Biologic Drugs Forecast by Application

13 Key Players Analysis

13.1 Roche

13.1.1 Roche Company Information

13.1.2 Roche Biologic Drugs Product Offered

13.1.3 Roche Biologic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Roche Main Business Overview

13.1.5 Roche Latest Developments

13.2 Abbott Laboratories

13.2.1 Abbott Laboratories Company Information

13.2.2 Abbott Laboratories Biologic Drugs Product Offered

13.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Abbott Laboratories Main Business Overview

13.2.5 Abbott Laboratories Latest Developments

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Company Information

13.3.2 Johnson & Johnson Biologic Drugs Product Offered

13.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Johnson & Johnson Main Business Overview

13.3.5 Johnson & Johnson Latest Developments

13.4 Merck & Co.

13.4.1 Merck & Co. Company Information

13.4.2 Merck & Co. Biologic Drugs Product Offered

13.4.3 Merck & Co. Biologic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck & Co. Main Business Overview

13.4.5 Merck & Co. Latest Developments

13.5 Pfizer

13.5.1 Pfizer Company Information

13.5.2 Pfizer Biologic Drugs Product Offered

13.5.3 Pfizer Biologic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Main Business Overview

13.5.5 Pfizer Latest Developments

13.6 Amgen

13.6.1 Amgen Company Information

13.6.2 Amgen Biologic Drugs Product Offered

13.6.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Amgen Main Business Overview

13.6.5 Amgen Latest Developments

13.7 Sanofi

13.7.1 Sanofi Company Information

13.7.2 Sanofi Biologic Drugs Product Offered

13.7.3 Sanofi Biologic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sanofi Main Business Overview

13.7.5 Sanofi Latest Developments

13.8 Novartis

13.8.1 Novartis Company Information

13.8.2 Novartis Biologic Drugs Product Offered

13.8.3 Novartis Biologic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novartis Main Business Overview

13.8.5 Novartis Latest Developments

13.9 Eli Lilly

13.9.1 Eli Lilly Company Information

13.9.2 Eli Lilly Biologic Drugs Product Offered

13.9.3 Eli Lilly Biologic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Eli Lilly Main Business Overview

13.9.5 Eli Lilly Latest Developments

13.10 Amgen

13.10.1 Amgen Company Information

13.10.2 Amgen Biologic Drugs Product Offered

13.10.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Amgen Main Business Overview

13.10.5 Amgen Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Biologic Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Biologic Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Humira

Table 4. Major Players of Remicade

Table 5. Major Players of Rituxan

Table 6. Major Players of Enbrel

Table 7. Major Players of Lantus

Table 8. Major Players of Avastin

Table 9. Major Players of Herceptin

Table 10. Major Players of Others

Table 11. Global Biologic Drugs Sales by Type (2017-2022) & (K Units)

Table 12. Global Biologic Drugs Sales Market Share by Type (2017-2022)

Table 13. Global Biologic Drugs Revenue by Type (2017-2022) & ($ million)

Table 14. Global Biologic Drugs Revenue Market Share by Type (2017-2022)

Table 15. Global Biologic Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 16. Global Biologic Drugs Sales by Application (2017-2022) & (K Units)

Table 17. Global Biologic Drugs Sales Market Share by Application (2017-2022)

Table 18. Global Biologic Drugs Revenue by Application (2017-2022)

Table 19. Global Biologic Drugs Revenue Market Share by Application (2017-2022)

Table 20. Global Biologic Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 21. Global Biologic Drugs Sales by Company (2020-2022) & (K Units)

Table 22. Global Biologic Drugs Sales Market Share by Company (2020-2022)

Table 23. Global Biologic Drugs Revenue by Company (2020-2022) ($ Millions)

Table 24. Global Biologic Drugs Revenue Market Share by Company (2020-2022)

Table 25. Global Biologic Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 26. Key Manufacturers Biologic Drugs Producing Area Distribution and Sales Area

Table 27. Players Biologic Drugs Products Offered

Table 28. Biologic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 29. New Products and Potential Entrants

Table 30. Mergers & Acquisitions, Expansion

Table 31. Global Biologic Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 32. Global Biologic Drugs Sales Market Share Geographic Region (2017-2022)

Table 33. Global Biologic Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 34. Global Biologic Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 35. Global Biologic Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 36. Global Biologic Drugs Sales Market Share by Country/Region (2017-2022)

Table 37. Global Biologic Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 38. Global Biologic Drugs Revenue Market Share by Country/Region (2017-2022)

Table 39. Americas Biologic Drugs Sales by Country (2017-2022) & (K Units)

Table 40. Americas Biologic Drugs Sales Market Share by Country (2017-2022)

Table 41. Americas Biologic Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 42. Americas Biologic Drugs Revenue Market Share by Country (2017-2022)

Table 43. Americas Biologic Drugs Sales by Type (2017-2022) & (K Units)

Table 44. Americas Biologic Drugs Sales Market Share by Type (2017-2022)

Table 45. Americas Biologic Drugs Sales by Application (2017-2022) & (K Units)

Table 46. Americas Biologic Drugs Sales Market Share by Application (2017-2022)

Table 47. APAC Biologic Drugs Sales by Region (2017-2022) & (K Units)

Table 48. APAC Biologic Drugs Sales Market Share by Region (2017-2022)

Table 49. APAC Biologic Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 50. APAC Biologic Drugs Revenue Market Share by Region (2017-2022)

Table 51. APAC Biologic Drugs Sales by Type (2017-2022) & (K Units)

Table 52. APAC Biologic Drugs Sales Market Share by Type (2017-2022)

Table 53. APAC Biologic Drugs Sales by Application (2017-2022) & (K Units)

Table 54. APAC Biologic Drugs Sales Market Share by Application (2017-2022)

Table 55. Europe Biologic Drugs Sales by Country (2017-2022) & (K Units)

Table 56. Europe Biologic Drugs Sales Market Share by Country (2017-2022)

Table 57. Europe Biologic Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 58. Europe Biologic Drugs Revenue Market Share by Country (2017-2022)

Table 59. Europe Biologic Drugs Sales by Type (2017-2022) & (K Units)

Table 60. Europe Biologic Drugs Sales Market Share by Type (2017-2022)

Table 61. Europe Biologic Drugs Sales by Application (2017-2022) & (K Units)

Table 62. Europe Biologic Drugs Sales Market Share by Application (2017-2022)

Table 63. Middle East & Africa Biologic Drugs Sales by Country (2017-2022) & (K Units)

Table 64. Middle East & Africa Biologic Drugs Sales Market Share by Country (2017-2022)

Table 65. Middle East & Africa Biologic Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 66. Middle East & Africa Biologic Drugs Revenue Market Share by Country (2017-2022)

Table 67. Middle East & Africa Biologic Drugs Sales by Type (2017-2022) & (K Units)

Table 68. Middle East & Africa Biologic Drugs Sales Market Share by Type (2017-2022)

Table 69. Middle East & Africa Biologic Drugs Sales by Application (2017-2022) & (K Units)

Table 70. Middle East & Africa Biologic Drugs Sales Market Share by Application (2017-2022)

Table 71. Key Market Drivers & Growth Opportunities of Biologic Drugs

Table 72. Key Market Challenges & Risks of Biologic Drugs

Table 73. Key Industry Trends of Biologic Drugs

Table 74. Biologic Drugs Raw Material

Table 75. Key Suppliers of Raw Materials

Table 76. Biologic Drugs Distributors List

Table 77. Biologic Drugs Customer List

Table 78. Global Biologic Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. Global Biologic Drugs Sales Market Forecast by Region

Table 80. Global Biologic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Global Biologic Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 82. Americas Biologic Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Americas Biologic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. APAC Biologic Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 85. APAC Biologic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 86. Europe Biologic Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Europe Biologic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Middle East & Africa Biologic Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 89. Middle East & Africa Biologic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Global Biologic Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 91. Global Biologic Drugs Sales Market Share Forecast by Type (2023-2028)

Table 92. Global Biologic Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 93. Global Biologic Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 94. Global Biologic Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 95. Global Biologic Drugs Sales Market Share Forecast by Application (2023-2028)

Table 96. Global Biologic Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 97. Global Biologic Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 98. Roche Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Roche Biologic Drugs Product Offered

Table 100. Roche Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Roche Main Business

Table 102. Roche Latest Developments

Table 103. Abbott Laboratories Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Abbott Laboratories Biologic Drugs Product Offered

Table 105. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Abbott Laboratories Main Business

Table 107. Abbott Laboratories Latest Developments

Table 108. Johnson & Johnson Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. Johnson & Johnson Biologic Drugs Product Offered

Table 110. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Johnson & Johnson Main Business

Table 112. Johnson & Johnson Latest Developments

Table 113. Merck & Co. Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. Merck & Co. Biologic Drugs Product Offered

Table 115. Merck & Co. Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Merck & Co. Main Business

Table 117. Merck & Co. Latest Developments

Table 118. Pfizer Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 119. Pfizer Biologic Drugs Product Offered

Table 120. Pfizer Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Pfizer Main Business

Table 122. Pfizer Latest Developments

Table 123. Amgen Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 124. Amgen Biologic Drugs Product Offered

Table 125. Amgen Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Amgen Main Business

Table 127. Amgen Latest Developments

Table 128. Sanofi Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 129. Sanofi Biologic Drugs Product Offered

Table 130. Sanofi Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Sanofi Main Business

Table 132. Sanofi Latest Developments

Table 133. Novartis Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 134. Novartis Biologic Drugs Product Offered

Table 135. Novartis Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Novartis Main Business

Table 137. Novartis Latest Developments

Table 138. Eli Lilly Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 139. Eli Lilly Biologic Drugs Product Offered

Table 140. Eli Lilly Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Eli Lilly Main Business

Table 142. Eli Lilly Latest Developments

Table 143. Amgen Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 144. Amgen Biologic Drugs Product Offered

Table 145. Amgen Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Amgen Main Business

Table 147. Amgen Latest Developments

List of Figures

Figure 1. Picture of Biologic Drugs

Figure 2. Biologic Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biologic Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Biologic Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Biologic Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Humira

Figure 10. Product Picture of Remicade

Figure 11. Product Picture of Rituxan

Figure 12. Product Picture of Enbrel

Figure 13. Product Picture of Lantus

Figure 14. Product Picture of Avastin

Figure 15. Product Picture of Herceptin

Figure 16. Product Picture of Others

Figure 17. Global Biologic Drugs Sales Market Share by Type in 2021

Figure 18. Global Biologic Drugs Revenue Market Share by Type (2017-2022)

Figure 19. Biologic Drugs Consumed in Diabetes

Figure 20. Global Biologic Drugs Market: Diabetes (2017-2022) & (K Units)

Figure 21. Biologic Drugs Consumed in Inflammation

Figure 22. Global Biologic Drugs Market: Inflammation (2017-2022) & (K Units)

Figure 23. Biologic Drugs Consumed in Auto-Immune Diseases

Figure 24. Global Biologic Drugs Market: Auto-Immune Diseases (2017-2022) & (K Units)

Figure 25. Biologic Drugs Consumed in Blood Diseases

Figure 26. Global Biologic Drugs Market: Blood Diseases (2017-2022) & (K Units)

Figure 27. Biologic Drugs Consumed in Cardiovascular Diseases

Figure 28. Global Biologic Drugs Market: Cardiovascular Diseases (2017-2022) & (K Units)

Figure 29. Biologic Drugs Consumed in Others

Figure 30. Global Biologic Drugs Market: Others (2017-2022) & (K Units)

Figure 31. Global Biologic Drugs Sales Market Share by Application (2017-2022)

Figure 32. Global Biologic Drugs Revenue Market Share by Application in 2021

Figure 33. Biologic Drugs Revenue Market by Company in 2021 ($ Million)

Figure 34. Global Biologic Drugs Revenue Market Share by Company in 2021

Figure 35. Global Biologic Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 36. Global Biologic Drugs Revenue Market Share by Geographic Region in 2021

Figure 37. Global Biologic Drugs Sales Market Share by Region (2017-2022)

Figure 38. Global Biologic Drugs Revenue Market Share by Country/Region in 2021

Figure 39. Americas Biologic Drugs Sales 2017-2022 (K Units)

Figure 40. Americas Biologic Drugs Revenue 2017-2022 ($ Millions)

Figure 41. APAC Biologic Drugs Sales 2017-2022 (K Units)

Figure 42. APAC Biologic Drugs Revenue 2017-2022 ($ Millions)

Figure 43. Europe Biologic Drugs Sales 2017-2022 (K Units)

Figure 44. Europe Biologic Drugs Revenue 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Biologic Drugs Sales 2017-2022 (K Units)

Figure 46. Middle East & Africa Biologic Drugs Revenue 2017-2022 ($ Millions)

Figure 47. Americas Biologic Drugs Sales Market Share by Country in 2021

Figure 48. Americas Biologic Drugs Revenue Market Share by Country in 2021

Figure 49. United States Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Canada Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Mexico Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Brazil Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. APAC Biologic Drugs Sales Market Share by Region in 2021

Figure 54. APAC Biologic Drugs Revenue Market Share by Regions in 2021

Figure 55. China Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Japan Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Korea Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Southeast Asia Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. India Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Australia Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Europe Biologic Drugs Sales Market Share by Country in 2021

Figure 62. Europe Biologic Drugs Revenue Market Share by Country in 2021

Figure 63. Germany Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. France Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. UK Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Italy Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. Russia Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. Middle East & Africa Biologic Drugs Sales Market Share by Country in 2021

Figure 69. Middle East & Africa Biologic Drugs Revenue Market Share by Country in 2021

Figure 70. Egypt Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 71. South Africa Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 72. Israel Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 73. Turkey Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 74. GCC Country Biologic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 75. Manufacturing Cost Structure Analysis of Biologic Drugs in 2021

Figure 76. Manufacturing Process Analysis of Biologic Drugs

Figure 77. Industry Chain Structure of Biologic Drugs

Figure 78. Channels of Distribution

Figure 79. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390